PanGenomic Health will purchase Mindleap Health for approximately $3 million. Mindleap Health is an app that connects users with mental health treatment, according to a Sept. 1 Mydecine news release.
“Given the recent narrowing of Mydecine’s business scope, we needed to find a group that we believe is capable of continuing the vision of Mindleap and taking it to the next level,” said Josh Bartch, CEO and chair of Mydecine. “We believe the PanGenomic Group is that group. Mindleap has over 40,000 organic downloads, and we believe this app has the potential to reach millions of users.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
